Moneycontrol PRO

business

See double-digit sales growth across markets in FY17: Wockhardt

Habil F Khorakiwala, founder, chairman and group CEO of Wockhardt says the company has replied to US food and drug administration (FDA) on issues related to its L1, Waluj and Shendra facilities and although a few issues are pending, he hopes it will be resolved soon

first published: Feb 16, 2016 12:39 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347